While the cellular source of IL-22 may differ depending on the model, the activation of the IL-22 pathway has shown benefit in both ulcerative colitis (UC) and Crohn’s disease (CD) in mice [4,5,6,7]. This evidence concerns the gene IL22 and Crohn disease.